Market cap
$799 Mln
Revenue (TTM)
$150 Mln
P/E Ratio
--
P/B Ratio
17.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -16.66 | 31.84 | 6.75 | 12.28 | 18.49 |
| EBIT | -374.64 | -27.50 | -98.94 | -220.82 | -226.89 |
| Net Profit | -214.53 | -83.05 | -1,227.95 | -321.33 | -300.72 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Apr-24 | Apr-23 |
| EBIT-Margin
| -0.26 | -2.06 | -17.75 | -16.15 | 2.48 |
| Net Margin
| 53.60 | 26.70 | -101.07 | -- | 0.37 |
| Return on equity
| -3.64 | -1.49 | -287.71 | -112.44 | 0.31 |
| Return on Capital
| 0.95 | -0.05 | -- | -43.48 | 0.15 |
| Return on Assets
| 0.37 | -0.14 | -32.73 | -35.74 | 0.13 |
| Debt to Equity (x)
| -- | -- | 3.44 | 3.41 | 1.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
--
|
-43.48
|
0.15
|
46.18
|
8.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-287.71
Lower than Peers by 306.68
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
-287.71
|
-112.44
|
0.31
|
101.22
|
18.74
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
ROA
-32.73
Lower than Peers by 35.58
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
-32.73
|
-35.74
|
0.13
|
36.72
|
6.01
|
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
EBIT Margin
-17.75
Lower than Peers by 33.57
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
-17.75
|
-16.15
|
2.48
|
12.89
|
12.77
|
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
Net Margin
-101.07
Lower than Peers by 109.30
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
-101.07
|
-100.60
|
0.37
|
106.82
|
11.68
|
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
6.75
Lower than Peers by 1.31
Year on year growth in net sales
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
6.75
|
-0.06
|
0.25
|
0.25
|
0.61
|
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
EBIT Growth
-98.94
Lower than Peers by 107.21
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
-98.94
|
-710.38
|
-76.00
|
25.97
|
191.91
|
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
Net Profit Growth
-1,227.95
Lower than Peers by 1,235.68
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
-1,227.95
|
-25,234.46
|
-99.56
|
1,038.71
|
254.52
|
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
3.44
Higher than Peers by 2.85
Total debt / Net worth
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
3.44
|
3.41
|
1.00
|
1.05
|
1.52
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.06
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
0.06
|
0.05
|
0.75
|
0.02
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.30
Lower than Peers by 0.35
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
1.30
|
1.47
|
1.53
|
2.38
|
2.93
|
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
Quick Ratio
0.92
Lower than Peers by 0.28
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
0.92
|
1.04
|
0.93
|
2.03
|
2.76
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
-3.19
Lower than Peers by 7.96
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
-3.19
|
-5.21
|
1.42
|
5.75
|
10.52
|
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
20.08
Lower than Peers by 1.19
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
20.08
|
20.73
|
18.70
|
21.67
|
26.03
|
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
Asset Turnover
0.32
Lower than Peers by 0.08
Sales / Average Total Assets
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
0.32
|
0.36
|
0.34
|
0.34
|
0.51
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
--
|
74.29
|
65.85
|
77.68
|
70.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
--
|
102.31
|
108.49
|
83.52
|
62.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
--
|
62.34
|
52.87
|
41.31
|
41.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
--
|
114.27
|
121.47
|
119.89
|
90.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
17.83
Higher than Peers by 10.08
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
17.83
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.75
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
EV/EBITDA
107.87
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
107.87
|
-14.40
|
13.81
|
2.83
|
-3.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
799
Lower than Peers by 1,792
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Apr-24
|
Apr-23
|
Apr-22
|
Apr-21
|
|---|---|---|---|---|---|
|
Avid Bioservices (CDMO)
|
799
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2,591
|
--
|
--
|
--
|
--
|